Clinical Trial Results Archive

Clinical Trial Results: July 2009

July 1 Human Genome Sciences to Host July 20 Conference Call to Discuss Top-Line Phase 3 Results for Benlysta (Formerly Lymphostat-B in Systemic Lupus Erythematosus
July 1 Pharming Confirms Positive Results From Fina l Analysis Of Rhucin Studies
July 1 New Review on Prostvac Published by Key Investigators From NCI
July 1 Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa
July 1 Study Showed Vyvanse (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment
July 1 Amira Pharmaceuticals Announces Initial Positive Phase 1 Clinical Data for AM211, a Novel Product Candidate for the Treatment of Respiratory Diseases
July 2 Sucampo Reports Top-Line Results of Phase 2 Clinical Trial of Cobiprostone for Prevention of NSAID-Induced Gastrointestinal Injuries
July 2 Lu AA24530 shows positive results in major depressive disorder phase II study
July 2 Sepracor Provides Update on Clinical Trials for SEP-225289 and LUNESTA Pediatrics
July 2 iCo Therapeutics Publishes Review of Diabetic Retinopathy Treatment
July 2 Phase III Study Showed Lucentis Improved Vision in Patients with Branch Retinal Vein Occlusion
July 6 5-Year Study Published in Diabetologia Demonstrated Long-Term Safety of Lantus Compared to NPH
July 6 Aeolus Pharmaceuticals' AEOL 10150 Significantly Increases Survival in Mice Exposed to Radiation when Administered After Exposure
July 6 New Online Resource Launches For Patients With Chronic Myeloid Leukemia
July 7 XOMA Announces Conference Call and Webcast On July 14 to Review Top Line Multi-dose and Other Results of Its Phase 1 Clinical Trial of XOMA 052 in Type 2 Diabetes
July 7 Vical Announces News Release and Conference Call/Webcast Schedule to Present TransVax CMV Vaccine Phase 2 Interim Efficacy Results
July 7 Published in The Lancet...Cervarix protects against the five most common cancer-causing virus types
July 7 Presse Release: Further interim analyses confirm good clinical efficacy of the BT-061 monoclonal antibody.
July 7 South Jersey Healthcare Selects MobileMD for Health Information Exchange Service
July 7 Stinson Brand Innovation, Inc. Releases White Paper Trends In Pharma Branding Over The Next Five Years
July 7 Denosumab Demonstrates Superiority Over Zometa in Pivotal Phase 3 Head-to-Head Trial in Breast Cancer Patients With Bone Metastases
July 7 EnVivo to Share Results of its EVP-6124 Phase Ib/IIa Trial at The International Conference on Alzheimer's Disease
July 7 Landmark Study for GSK's Cervical Cancer Vaccine Published in The Lancet
July 7 AEterna Zentaris: New Data Published on its Ghrelin Antagonist Compound, AEZS-123 (JMV2959), Supports its Use in Alcohol Addiction
July 8 ARYx Therapeutics Announces Results of Phase 2/3 Clinical Trial on Anticoagulant Agent Tecarfarin
July 8 Livingston Securities ?Healthcare Investment Series? Webinar Covers Emerging Models for Pharma Exits and Deals
July 8 Beacon Solutions Announces New Purchase Order from Fortune 500 Pharmaceutical Company
July 8 BioCis Pharma Reports Positive Phase IIa Clinical Results in Atopic Dermatitis
July 8 McKesson Provider Technologies Deploys Synygy Sales Performance Management Solution
July 8 Digital Consumer Solutions Inc Launches DCSI Content Network
July 8 Vical TransVax CMV Vaccine Achieves Promising Interim Clinical Results in Phase 2 Trial
July 9 Revance Therapeutics Announces Efficacy of Topical Botulinum Toxin Type A for the Treatment of Facial Wrinkles
July 9 Elan to Showcase Its Leadership in Alzheimer's Disease at Upcoming International Meeting
July 9 Array BioPharma Announces Top-Line Results in Two Phase 1 Clinical Trials
July 9 Rigel's R788 Significantly Improves Rheumatoid Arthritis in Phase 2b Clinical Trial
July 9 Data Published in The New England Journal of Medicine Support Use of Raxibacumab (ABthrax) for the Treatment of Inhalation Anthrax
July 9 Amylin Pharmaceuticals Announces Positive Results from Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment for Obesity
July 9 Questcor Launches New Corporate Website
July 9 Physicians and Pharmacists Reach for OTC Relief With New Epocrates Reference
July 9 Iontophoretic Drug Delivery System (IDDS) Containing Lidocaine and Epinephrine is Effective in Reducing Pain Associated With Insertion of an Intravenous Catheter in a Phase 2 Clinical Trial
July 13 Elan and Transition Therapeutics Announce Phase 1 Data Showing ELND005 Achieves Desired Concentrations in Brain Tissue and Cerebrospinal Fluid
July 13 New Data from Phase III SATURN Study Showed Tarceva Improved Overall Survival When Used Immediately After Initial Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer
July 13 CytRx's INNO-206 Demonstrates Statistically Significant Tumor Shrinkage in Animal Trial for Breast Cancer
July 14 Maxygen Announces Positive Results of MAXY-G34 Phase IIa Study in Breast Cancer Patients
July 14 Noven Reports Positive Phase 2 Results for Mesafem Non-Hormonal Therapy for Vasomotor Symptoms
July 14 IP Advocate Enhances Interactive IPAO Forum with New ?Expert Opinions' Section
July 14 Safety and Cognitive Stability Are Key Findings in Phase IIA Trial of New Alzheimer's Disease Treatment from Humanetics Corporation
July 14 Light-directed drug delivery system slows growth of invasive tumours
July 14 Oxford Biomedica Announces Update On Phase I/Ii Study Of Prosavin In Parkinson's Disease
July 14 Avid Radiopharmaceuticals Phase II Results Featured in Two Presentations at Alzheimer's Association 2009 International Conference on Alzheimer's Disease (ICAD)
July 14 New Podcast in Patient Perspectives Series: Searching for a Cure
July 14 EnVivo Pharmaceuticals Announces Reversal of Cognitive Deficits in Alzheimer's Disease Transgenic Mouse Model With Gamma-Secretase Modulator
July 14 Study Evaluating Efficacy and Safety of Two Low-dose Regimens of Premarin Vaginal Cream for the Treatment of Moderate to Severe Vaginal Atrophy Now Published
July 14 Endocyte to Present Data on EC145 at the IASLC 13th World Conference on Lung Cancer
July 14 ParagonRx Creates New Website Featuring REMS Help Center for Pharma
July 14 Patient Enrollment Complete for Phase I/II Clinical Trial for GALNS for Morquio A Syndrome
July 14 Analysis of Four Large Post-Marketing Surveillance Studies Describe Clinical Effects of Sucrose-Formulated Recombinant Factor VIII
July 15 I-many Government Pricing Goes Live at Graceway Pharmaceuticals
July 15 Abraxis BioScience Completes Enrollment of Pivotal Phase III Advanced Lung Cancer Study Evaluating ABRAXANE Vs. Taxol
July 15 Targacept's TC-5214 Achieves All Primary and Secondary Outcome Measures in Phase 2b Trial as Augmentation Treatment for Major Depressive Disorder
July 15 Oncolytics Biotech Inc. Research Collaborators Present Glioma Reovirus Research at ASV Annual Meeting
July 15 Analysis of Edoxaban Phase II Data Provides Insight Into Reduced Bleeding Events Seen in Once-Daily Dosing
July 15 A Phase III Alzheimer's Drug Increases Levels of Beta Amyloid in the Brain - But Still Provides Benefits
July 15 Results From Drug Trials and New Risk Factors Announced at International Alzheimer's Conference
July 15 Pfizer Announces New Phase 1 Data From Two Novel Compounds For Alzheimer's Disease At ICAD Annual Meeting
July 15 Sapient Delivers New Online Multilingual Resource to Support Thousands of Families Affected by Rare Congenital Syndrome
July 15 ReachMD Announces a New Radio Programming Series, ?Diabetes Discourse,? hosted by Steven V. Edelman, MD
July 16 National Survey Indicates Latinos and Blacks in America Twice as Likely as Caucasians to Be Diagnosed with Diabetes
July 16 Results of Phase I and Phase IIa Clinical Studies Confirm the Inhibitory Effect of Proprietary Ipsen's BIM23A760 First-in-Class ?Chimeric? Compound on Growth Hormone, IGF-1 and Prolactin Levels1
July 16 Inovio Biomedical H1N1 Influenza DNA Vaccines Demonstrate 100% Responses Against Swine Flu in Vaccinated Pigs
July 16 avVaa World Health Care Products Inc. Announces Web Site Design for Neuroskin Psoriasis Relief DRTV Campaign
July 16 Results of Phase I and Phase IIa clinical studies confirm the inhibitory effect of proprietary Ipsen?s BIM23A760 first-in-class ?chimeric? compound on growth hormone, IGF-1 and prolactin levels
July 16 Penwest Announces Results of Phase Ib Trial of A0001
July 16 Targacept?s TC-5214 Achieves All Primary and Secondary Outcome Measures in Phase 2b Trial as Augmentation Treatment for Major Depressive Disorder
July 16 Raptor Pharmaceuticals Corp. to Present at 2009 Cystinosis Research Network Family Conference
July 16 XOMA Announces Positive Results From U.S. Phase 1 Trial of XOMA 052 in Type 2 Diabetes
July 16 Oncolytics Biotech Inc. Announces Publication of Research on Synergistic Activity of Reovirus and Chemotherapy in NSCLC
July 16 Former AMA Chief and Other Members of the Coalition to Protect Patients' Rights to Hold Press Conference to Discuss Health Reform
July 17 Bionovo's Estrogen Receptor Beta Selective Drugs Have Unique Gene Expression and Cell Type Specificity
July 17 BioCryst Pharmaceuticals Reports Positive Results of Shionogi & Co. Sponsored Phase 3 Studies of i.v. Peramivir for Influenza
July 17 PolyMedix to Present at 5th International AIDS Society (IAS) Conference
July 19 Data on PolyMedix Heptagonist Compounds Presented at the International Society on Thrombosis and Hemostasis (ISTH) Conference
July 20 Alnylam and Cubist Announce Complete Data from Phase II Study of ALN-RSV01 in Lung Transplant Patients Naturally Infected with Respiratory Syncytial Virus
July 20 First Potential Lupus-Specific Treatment in Sight
July 20 Debate Over Advertising Prescription Drugs to Consumers Goes Online at New ProCon.org Website
July 21 Xeloda-Oxaliplatin Combination (XELOX) Shown to Be More Effective Than Standard Chemotherapy Regimen in Adjuvant Colon Cancer
July 21 Isentress (raltegravir), from Merck, was as Effective as Efavirenz at Suppressing HIV Viral Load and Increasing CD4 Cell Counts in Treatment-Naïve Patients up to 144 Weeks When Used in Combination Therapy
July 21 Exenatide Once Weekly Provided Superior Glucose Control Compared To Lantus in Head-to-Head DURATION-3 Study
July 21 96-Week MERIT ES Analysis Shows Efficacy Of Pfizer's HIV/AIDS Treatment Celsentri/Selzentry (Maraviroc) In Treatment-Naïve HIV Patients; Results Consistent With 48-Week Analysis
July 21 Foresight Biotherapeutics Announces Positive Results from an Open Label Pilot Study in Patients with Viral Conjunctivitis
July 21 Thermo Fisher Scientific Showcases Breadth of Clinical Chemistry Solutions at AACC 2009
July 21 Oramed Pharmaceuticals Reports Positive Results From a Study of Oral Insulin Capsule on Type 1 Diabetic Patients
July 21 Isentress (raltegravir), from MSD, was as Effective as Efavirenz at Suppressing HIV Viral Load and Increasing CD4 Cell Counts in Treatment-Naïve Patients up to 144 Weeks When Used in Combination Therapy
July 21 Raltegravir as Effective as Efavirenz at Suppressing HIV Viral Load and Increasing CD4 Cell Counts in Treatment-Naive Patients Up to 144 Weeks When Used in Combination Therapy
July 21 Orexigen Successfully Meets Phase 3 Endpoints in Obesity Trials
July 22 Takeda and Sucampo Report Top-Line Results of Two Phase 3 Trials of Lubiprostone in Opioid-Induced Bowel Dysfunction
July 22 -Contrave Obesity Research Phase 3 Program Meets Co-Primary and Key Secondary Endpoints; Exceeds FDA Efficacy Benchmark for Obesity Treatments-
July 22 Actelion's PGI2 receptor agonist demonstrates efficacy in pulmonary arterial hypertension patients - Morbidity-Mortality Phase III study to be initiated before year-end
July 22 The American Academy of Pharmaceutical Scientists (AAPS) Hires Environics Communications to Provide PR for Annual Meeting
July 22 96-Week Safety and Efficacy Findings Presented for Intelence (etravirine) As Part of HIV Combination Therapy
July 22 AlphaVax Announces Results from Initial Testing of Its H1N1 (Swine) Influenza Vaccine
July 22 BIO Issues Call for Sessions for 2010 BIO International Convention
July 22 Data Show ATryn Effectively Prevents Serious Blood Clots in Patients with Hereditary Antithrombin Deficiency
July 22 FoldRx Pharmaceuticals Announces Positive Results from Pivotal Phase II/III Clinical Study of Tafamidis
July 22 Siemens Showcases Innovative Products and Educational Offerings
July 22 Access Pharmaceuticals to Present at Jesup & Lamont 2009 Growth Stock Conference
July 22 Study Published in Child and Adolescent Psychiatry and Mental Health Demonstrated Once-Daily Vyvanse (lisdexamfetamine dimesylate) CII Provided Significant Improvement of ADHD Symptoms for Children at 13 Hours After Administration
July 22 NCCN Will Convene National Policy Summit on Comparative Effectiveness in Cancer Care
July 22 Nexavar in Combination with Chemotherapy Shown to Extend Progression-Free Survival in Patients with Advanced Breast Cancer
July 22 Seattle Genetics to Host Conference Call and Webcast Discussion of Second Quarter 2009 Financial Results on July 23, 2009
July 22 PolyMedix to Present at 5th International AIDS Society (IAS) Conference Cape Town, South Africa
July 22 New Results From ARTEN Study of Nevirapine Plus Tenofovir and Emtricitabine (TDF/FTC) Versus Boosted Protease Inhibitor Regimen of Atazanavir/Ritonavir Plus TDF/FTC Revealed
July 22 SoCalBio's 11th Investor & Partnership Conference to Explore Post-Recession Funding Strategies for Life Science Firms
July 22 New HIV Study Shows That Large Numbers of Women and People of Color Can Be Successfully Enrolled In U.S. HIV Clinical Studies
July 22 Merck Issues Statement on WHO Study Showing First Evidence That Elimination of River Blindness is Feasible in Africa
July 23 Rigel to Host Conference Call to Discuss Results of Its Phase 2b TASKi3 Clinical Trial of R788 in Rheumatoid Arthritis
July 23 Landmark Five-Year African Study Indicates That HIV Therapy May Be Given Safely in Resource-Limited Settings Without Routine Laboratory Monitoring
July 23 Millennium Laboratories Research Study Reveals Lower Opiate Cutoff Levels Identify Higher Percentage of Patients Taking Illegal Drugs
July 23 Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for Benlysta in Systemic Lupus Erythematosus
July 24 Orexo announces positive Phase III results for KW-2246 in Japan
July 24 R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies - Results Incongruent
July 24 Advancing Adaptive Design and Personalized Medicine in CNS Trials: Clinical, Regulatory and Statistical Viewpoints
July 24 Chinese Scientist Fanyi Zeng to Present at World Stem Cell Summit on iPS Cells Producing Viable Mice
July 24 ChemOutsourcing Unveils 2009 Attendee List for September Show in New Jersey
July 27 ARIAD Announces Preliminary Results from Ongoing Clinical Trial of Its Investigational, Bcr-Abl Inhibitor ? AP24534 ? in Drug-Resistant Chronic Myeloid Leukemia
July 27 Inovio Biomedical Universal Dengue DNA Vaccine Demonstrates Strong Immune Responses Against All Four Serotypes
July 28 Wyeth Reports Publication of Phase 3 Data for Bazedoxifene/Conjugated Estrogens, an Investigational Compound Being Studied for the Treatment of Menopausal Symptoms
July 28 Unlikely Treatment Identified by BrainCells Neurogenesis Platform Improved Clinical Outcomes in Patients Suffering From Depression
July 28 Quark Pharmaceuticals Announces Data Indicating Potential Utility of QPI-1007 for Treatment of Glaucoma
July 28 Saphris (asenapine) Meets Primary Endpoint in Long-Term Extension Study in Patients With Predominant, Persistent Negative Symptoms of Schizophrenia
July 28 Suven Presented Positive Phase-I clinical data of SUVN-502 for Alzheimer's disease at ICAD 2009, Vienna, Austria
July 28 NeurogesX Announces Preliminary Results of FDA-Requested Qutenza Study
July 28 Dirucotide Does Not Meet Primary Endpoint in Phase III MAESTRO-01 Trial in Secondary Progressive Multiple Sclerosis
July 28 CytRx Drug Candidate INNO-206 Results in Ovarian Tumor Shrinkage in Animal Trials
July 28 Economy is Driving Many Osteoporotic Women to Retire Later - But Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease
July 28 Ongoing Study Shows That Endovascular Therapy is Associated With High Cure Rate for Childhood Eye Cancer
July 28 Biofrontera AG (DE) - Ad hoc: Clinical study with BF-derm1 shows efficacy in severe chronic urticaria
July 28 Study Shows Cancer Vaccines Led to Long-Term Survival for Patients with Metastatic Melanoma and to Long Periods of Disease Control After Completion of Therapy
July 29 DURECT to Present at the BMO Capital Markets Healthcare Conference
July 29 ImmuneRegen BioSciences Confirms Homspera's Therapeutic Anti-Influenza Effect on Pandemic H1N1 Influenza Virus After Oral Administration
July 29 QuatRx Announces Further Positive Phase 3 Results For Ophena (Ospemifene Tablets) in Postmenopausal Vaginal Atrophy
July 29 NanoBio to Announce Key Preclinical Data on Nanoemulsions for the Treatment of Acne at American Academy of Dermatology Summer Meeting
July 29 Sciele Pharma and Plethora Solutions Announce Positive Results of Final Phase III Pivotal Trial for PSD502 for Premature Ejaculation
July 29 Foundation for the National Institutes of Health Announces 2009 mHealth Summit
July 29 Elagolix Successful in Six Month Lilac Petal Study; Safety and Efficacy Confirmed in Patients With Endometriosis
July 30 Obagi Medical Products Releases Results of a Clinical Trial Showing Optimized Patient Outcomes When Condition & Enhance System is Used in Combination with Botulinum Toxin Type A
July 30 Obagi Medical Products Reveals Results of a Meta-Analysis Comparing the Company's Novel 5 Percent Solubilized BPO to Other Prescription 5 Percent BPO and Combination BPO/Clindamycin Topical Products
July 30 Stemline Therapeutics CEO to Present at IBC's New Frontiers in Cancer Drug Development Conference
July 30 Child and Adolescent Psychiatry and Mental Health Publishes Vyvanse ADHD Data
July 30 Cardinal Health Welcomes Record Number of Attendees at its Annual Independent Pharmacy Trade Show
July 30 Teva's Forum Draws Key Pennsylvania Healthcare Leaders
July 30 Medicago's H1N1 pandemic vaccine candidate shows positive response in 100% of vaccinated animals after a single dose
July 31 Pharmasset Reports Positive Preliminary Antiviral Data With PSI-7851 for the Treatment of Hepatitis C
July 31 Clinical Trial by Licensee Does Not Meet Primary Endpoint
July 31 Second Phase III Study Showed Lucentis Improved Vision in Patients With Retinal Vein Occlusion
July 31 AVEO's Tivozanib Demonstrates Anti-Tumor Activity in Engineered Lung Tumors Exhibiting Treatment Resistant Mutations
July 31 17 Regional Companies Accepted During First-Round Vetting for the Inaugural Rocky Mountain Life Science Investor Conference, September 17th in Denver
July 31 Obagi Medical Products' CLENZIderm M.D. Serum Gel Significantly Reduces Non-Inflammatory Lesions with Visible Results as Early as Week One

Clinical Trial Results Archive

2009: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov
2008: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Dec

MedNotes
Advertisement

(web4)